Controlled-release technology was, in fact, another type of pharmaceutical formulation, and the most unusual one at that.
It could be considered an upgraded version of sustained-release technology. Both reduced the rate at which a drug was released, prolonging its effects while reducing its toxicity and side effects.
The difference was that sustained-release technology did not release drugs at a constant rate. The release rate of sustained-release capsules fluctuated, generally starting fast and then slowing down, and could also change for various reasons.
Controlled-release tablet technology, on the other hand, allowed a drug to be released steadily at a constant rate. The amount released per unit of time remained constant or fluctuated only slightly, and the effects could last longer, generally reaching twenty-four hours or more.
This meant that for conditions such as hypertension, which required a continuous supply of medication to keep blood pressure balanced, a drug made using controlled-release tablet technology only needed to be taken once a day, one tablet at a time, avoiding the hassle of repeated doses.
At the same time, because the drug was released very slowly and steadily, this also indirectly reduced its toxicity and side effects. The body could actually metabolize many toxins slowly, and it could also adapt to and gradually recover from most other side effects.
A smaller dose at any one time produced fewer side effects, allowing the body to adapt and recover. It was like the difference between slowly sipping liquor and downing half a liter in one go. The dosage might appear identical, but different methods of consumption produced vastly different side effects.
The same applied to the Superbrain Drug.
What he had previously done by dissolving the Superbrain Drug in water and taking it in multiple doses had actually produced a very similar effect. He reduced the